Literature DB >> 8392973

Changes in complement and immunoglobulin G receptor expression on neutrophils associated with Porphyromonas gingivalis-induced inhibition of phagocytosis.

H Tai1, T Kobayashi, K Hara.   

Abstract

We examined the phagocytic capacity and receptor expression on neutrophils stimulated with Porphyromonas gingivalis soluble products. Stimulated neutrophils had decreased phagocytic capacities and altered expression of CR1, CR3, Fc gamma RII, and Fc gamma RIII. For cases in which TLCK (N-alpha-p-tosyl-L-lysine chloromethyl ketone) neutralized the effects of the stimuli, the P. gingivalis-derived factors causing the phenomena seem to be trypsin-like proteases.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8392973      PMCID： PMC281034          DOI： 10.1128/iai.61.8.3533-3535.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  26 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Inhibition of neutrophil chemotaxis by soluble bacterial products.

Authors:  T E Van Dyke; E Bartholomew; R J Genco; J Slots; M J Levine
Journal:  J Periodontol       Date:  1982-08       Impact factor: 6.993

3.  Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis.

Authors:  J A Wingrove; R G DiScipio; Z Chen; J Potempa; J Travis; T E Hugli
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

4.  Characterization of a trypsin-like protease from the bacterium Bacteroides gingivalis isolated from human dental plaque.

Authors:  F Yoshimura; M Nishikata; T Suzuki; C I Hoover; E Newbrun
Journal:  Arch Oral Biol       Date:  1984       Impact factor: 2.633

5.  Neutrophil receptor modulation in the pathogenesis of periodontal diseases.

Authors:  T E Van Dyke
Journal:  J Dent Res       Date:  1984-03       Impact factor: 6.116

6.  Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity.

Authors:  B H Kushner; N K Cheung
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

7.  Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.

Authors:  J J O'Shea; E J Brown; B E Seligmann; J A Metcalf; M M Frank; J I Gallin
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

8.  The up- and down-modulation of immunoglobulin G Fc receptors and complement receptors on activated human neutrophils depends on the nature of activator.

Authors:  L Leino; E M Lilius
Journal:  J Leukoc Biol       Date:  1992-02       Impact factor: 4.962

9.  Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes.

Authors:  D L Gordon; G M Johnson; M K Hostetter
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

10.  Human neutrophils increase expression of C3bi as well as C3b receptors upon activation.

Authors:  M Berger; J O'Shea; A S Cross; T M Folks; T M Chused; E J Brown; M M Frank
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808
View more
  3 in total

1.  Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration.

Authors:  P N Madianos; P N Papapanou; J Sandros
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Effective in vitro clearance of Porphyromonas gingivalis by Fc alpha receptor I (CD89) on gingival crevicular neutrophils.

Authors:  T Kobayashi; K Yamamoto; N Sugita; A B van Spriel; S Kaneko; J G van de Winkel; H Yoshie
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Phagocytic activity of peripheral blood and crevicular phagocytes in health and periodontal disease.

Authors:  K Asif; Shaila V Kothiwale
Journal:  J Indian Soc Periodontol       Date:  2010-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.